Navigation Links
MSD Wellcome Trust Hilleman Laboratories announces first project
Date:1/25/2011

(New Delhi, 25 January 2011) -- The MSD Wellcome Trust Hilleman Laboratories announced today that the organization's first project will be a feasibility study into how new technologies might be used to develop a rotavirus vaccine designed specifically with developing country needs in mind. Formulations based on dissolving thin strips or granules will be examined for their potential to improve product stability, ease of use, transportation and affordability. The therapeutic focus of the project has been selected because of the tremendous global impact of rotavirus diarrhea on childhood mortality. If the initial study is successful, options to further develop the technology for rotavirus and other oral vaccines of importance to developing country health will be explored.

"Many first-generation vaccines have not been developed with the specific needs of countries with poor infrastructure for vaccine delivery in mind. This is a much needed exploration of how to tackle one of the greatest public health and logistics challenges in the developing world -- distributing life-saving vaccines without the requirement for large bulk shipments, expensive warehousing and costly, difficult-to-maintain refrigerated shipping paths from the manufacturing plant to the patient," says Hilleman Laboratories Chief Executive Officer, Dr. Altaf A. Lal.

The project is a collaboration among the Hilleman Laboratories, MSD and Medicine in Need (MEND), an international non-profit organization specializing in the application of advanced vaccine formulation technologies. For this feasibility study, MEND is providing the formulation technology and MSD is providing components of its existing rotavirus vaccine.

"With developing country needs in mind, we are targeting heat stability, ease of administration, package size, and cost of goods as key features of the product," said Dr. Akshay Goel, Chief Scientific Officer at Hilleman Laboratories.

"MEND's mission is to formulate life-saving vaccines in ways that allow their availability and sustainability to the impoverished populations who need them most," said Dr. Andrew Schiermeier, CEO at MEND. "Our collaboration with Hilleman Labs and the MSD vaccines group provides an excellent opportunity to leverage the technical expertise of the different groups with the aim of creating a product that will be far-better suited for developing country needs."

"This technology has the potential to be a real game changer in vaccine development and delivery," said Dr. David Heymann, Chairman of the UK's Health Protection Agency who also chairs the Strategic Advisory Group of the Hilleman Laboratories. "This kind of R&D is needed to make effective vaccines available in resource limited countries, so that they can be more easily used to decrease the impact of vaccine preventable diseases. There is tremendous synergy in bringing together the philanthropic, scientific and business prowess of these organizations and their funders to benefit so many of the world's poorest."

The World Health Organization estimates that annually from 10 percent up to 50 percent of vaccines may be wasted globally because of temperature control, shipping, and other logistical issues.

"Although a potential vaccine coming out of the Hilleman Laboratories would be for global needs, nearly 100,000 rotavirus deaths each year occur in India," said Dr. M. K. Bhan, Secretary to the Government of India, Department of Biotechnology, Ministry of Science and Technology. "The Hilleman Laboratories effort to extend the utility of rotavirus vaccine in poor countries is to be welcomed."


'/>"/>

Contact: Samantha Cranko
samanthac@rabinpartners.com
917-453-0346
MSD Wellcome Trust Hilleman Laboratories
Source:Eurekalert

Related medicine news :

1. Medibank Health Solutions: The New Name to Trust in Workplace Health
2. BioMed Realty Trust Reports Fourth Quarter and Full-Year 2009 Financial Results
3. Three NHS Trusts Choose BigHand Voice Technology Under YHCPC Framework Agreement
4. BestMassage.com Receives Award for Customer Trust
5. BioMed Realty Trust Promotes Matthew G. McDevitt to Executive Vice President, Real Estate
6. Healthcare Trust of America, Inc. Executes Agreement to Acquire an Approximately 260,500 Square Foot Medical Office Portfolio in Indiana
7. Healthcare Realty Trust Announces Fourth Quarter Results
8. PIA Hails Removal of Medical Malpractice Insurers From Bill Restricting Insurance Antitrust Exemption
9. Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results
10. Pelosi, Senior Democrats Remarks at News Conference on Repealing Health Insurance Industry Anti-Trust Exemption
11. Healthcare Trust of America, Inc. Executes Agreement to Acquire an Approximately 60,300 Square Foot Medical Office Building in Sugar Land, Texas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... 2016 , ... Christie Medical Holdings, Inc. presented the Baylor ... Vision vein finder for the nursing school simulation lab. This donation ... blood, combining technology with traditional technique. , “VeinViewer is a wonderful new addition ...
(Date:2/12/2016)... ... February 12, 2016 , ... According to an ... beginning to account for a significant portion of hernia repairs throughout the United States. ... Beverly Hills Hernia Center notes that this trend has not only been expected, but ...
(Date:2/12/2016)... ... February 12, 2016 , ... The ... funding innovative lymphoma research and serving the lymphoma community through a comprehensive series ... of South Florida’s philanthropic community at its 10th anniversary Fashion Luncheon on Monday, ...
(Date:2/12/2016)... , ... February 12, 2016 , ... As a former ... schedule, a demanding job, and no time to decompress, Rabinowitz found herself drawn to ... to meditation for its impact on her life, implementing a 20-minute-per-day meditation practice with ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... Service (WaaS), today announced the integration of Clarity Intelligence Platform (CIP) into Cielo®, ... to offer real-time business intelligence (BI) to their small and medium business (SMB) ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... BUDAPEST , Ungarn, February 12, 2016 ... ein Medizintechnikunternehmen, das sich auf den ungedeckten ... gab heute positive Ergebnisse seines klinischen Forschungsprogramms ... und Asthma-Patienten beschäftigt, ergab Verbesserungen ihrer respiratorischen ... Indiso ltd , ein Medizintechnikunternehmen, das ...
(Date:2/11/2016)... , Feb. 11, 2016 The primary goal ... future adoption patterns on the usage of liquid biopsy. ... following: - Timeframe of liquid biopsy adoption ... cfDNA and Evs—by organization type - Sample inflow to ... blood, saliva, stool, serum, and so on. - Correlation ...
(Date:2/11/2016)... 11, 2016 Laboratory glassware and ... laboratories. These may range from microscope slides to large ... made from borosilicate glass because of its low weight ... other hand, started gaining popularity over the past decade ... replace glass with plastic in several applications due to ...
Breaking Medicine Technology: